Programme Introduction
About this programme
🩺 Medical CME
✅ Case-Based Learning
📊 Guideline-Aligned
This CME programme addresses one of the most consequential challenges in modern clinical care: protecting immunocompromised patients from infections that, in a healthy host, might be minor but in this population can rapidly become life-threatening. It covers the biology of impaired immune function alongside the infection prevention and control practices that reduce risk for these vulnerable patients.
Patients with weakened immune systems — whether from chemotherapy, transplant-related immunosuppression, haematological malignancy, or other causes — face a materially different risk profile than the general patient population. Recognising who is at elevated risk, understanding why, and knowing which prevention strategies actually reduce harm are core competencies for the oncology, transplant, and infectious disease teams who care for them.
TerraLeap’s programme uses realistic, case-based scenarios drawn from oncology, haematology, and transplant settings to build this competency systematically — moving from risk assessment through to prevention, early recognition, and coordinated multidisciplinary response.
Learners finish the programme with a structured framework for reducing healthcare-associated infection risk in immunocompromised populations and improving outcomes across their care teams.
Guideline-aligned reasoning — built through real clinical case discussion.
Programme Scope
What this programme covers
The programme spans everything from immune biology to practical prophylaxis and outbreak management in immunocompromised care settings.
🧬
Immune function fundamentals
The physiological factors that impair immune defences and elevate infection susceptibility.
🎯
Risk stratification
Identifying which patients face the highest infection risk based on their underlying condition and treatment.
🏥
Infection prevention practices
Evidence-based measures for reducing healthcare-associated infection in oncology, transplant, and haematology units.
🩺
Early recognition
Spotting subtle early signs of infection in patients whose immune response may not present typically.
🌍
Outbreak management
Containing and managing infection clusters within immunocompromised patient populations.
👥
Multidisciplinary collaboration
Coordinating across oncology, transplant, and infectious disease teams to manage shared patients.
Learning Objectives
What you will achieve
This programme builds the judgement needed to protect immunocompromised patients from avoidable infection risk.
Case-based learning connects risk assessment directly to prevention practice and team coordination.
01
Explain the factors that impair immune function and elevate infection risk in specific patient groups.
02
Identify high-risk individuals early, using clinical and treatment-history indicators.
03
Implement evidence-based prevention practices tailored to oncology, transplant, and haematology settings.
04
Recognise early warning signs of infection that may present atypically in immunosuppressed patients.
05
Coordinate outbreak containment within units caring for immunocompromised populations.
06
Collaborate across specialties with oncology, transplant, and infectious disease colleagues on shared cases.
07
Reduce healthcare-associated infection rates through consistent application of prevention protocols.
08
Support improved patient outcomes through vigilant, proactive infection risk management.
Target Audience
Who can enroll
This CME programme on immunocompromised patient infection control is intended for oncology, transplant, and infectious disease teams who manage patients at heightened infection risk.
It is equally valuable for any clinician or nurse who cares for patients undergoing immunosuppressive treatment and needs a structured framework for infection prevention and early recognition.
🩺
Oncologists managing patients undergoing chemotherapy or other immunosuppressive cancer treatment.
🧪
Hematologists treating patients with blood disorders affecting immune function.
🦠
Infectious disease specialists consulting on complex cases in immunocompromised patients.
🏥
Transplant coordinators overseeing peri- and post-transplant patient care pathways.
💉
Nurses delivering direct bedside care in oncology, transplant, and haematology units.
📋
Other healthcare providers working across oncology, hematology, and transplant care units.
Programme Certification
Your certificate
Upon successful completion of this programme, you will receive a digital certificate recognising your achievement and the competencies you have acquired throughout the course.
Certificates for TerraLeap programmes are issued and signed by authorised TerraLeap representatives. For programmes delivered in collaboration with universities, institutions, or industry organisations, certificates are jointly issued and co-signed by authorised representatives of both TerraLeap and the respective partner.
Each certificate carries a unique Certificate ID and QR code to enable instant authenticity verification — making it easy to share with employers, licensing bodies, or professional networks as evidence of your learning.
Note on scope. TerraLeap certificates confirm successful completion of the respective programme and recognise your professional development and continuing education. They do not constitute a professional licence or regulatory authorisation unless explicitly stated in the programme description.
TERRALEAP
Certificate ID
TL-2026-AB7K3X9P
Official
Seal
Certificate of Completion
Successfully Completed
Awarded in recognition of academic achievement
This is to certify that
XXXXX
has successfully completed the prescribed course of study, demonstrating commitment, diligence, and proficiency in
Immunocompromised Care: Infection Control Strategies
and is hereby awarded this certificate by TerraLeap, recognising the candidate's mastery of the syllabus and successful evaluation.